Novartis Adds Wyeth To Hemophilia Patent Hit List
Swiss drugmaker Novartis AG has filed an amended complaint against Wyeth Pharmaceuticals Inc. in a patent infringement suit over ReFacto and Xyntha hemophilia treatments....To view the full article, register now.
Already a subscriber? Click here to view full article